Global C-Reactive Protein Testing Market, By Assay Type (Immunoturbidimetric Assay, ELISA, Chemiluminescence Immunoassay, Others), Detection Range (hs-CRP, Conventional CRP, cCRP), Disease (Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, Syphilis, Inflammatory Diseases, Diabetes, Others), Analysis Mode (Serum, Plasma, Blood), End-User (Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home, Others), Product Type (Kits, Reagents)- Industry Trends and Forecast to 2029
Market Analysis and Size
Increased C-reactive protein levels are linked to an increased risk of heart attacks; however, the C-reactive protein test does not identify the direct cause of inflammation but rather the level of inflammation produced by other factors. The C-reactive protein test is utilized in patients who have a low chance of having a heart attack in the next few years, about 5% to 10%.
Data Bridge Market Research analyses that the C-reactive protein market was valued USD 5.53 billion in 2021, would rocket up to USD 6.06 billion by 2029, and is expected to undergo a CAGR of 1.15% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
The C-reactive protein (CRP) test determines the amount of C-reactive protein (CRP) in the blood. The C-reactive protein (CRP) test is used to check for infections or other medical disorders, and it rise when there is inflammation. The C-reactive protein test assesses the risk of developing cardiovascular conditions, including coronary artery disease, leading to a significant heart attack.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Assay Type (Immunoturbidimetric Assay, ELISA, Chemiluminescence Immunoassay, Others), Detection Range (hs-CRP, Conventional CRP, cCRP), Disease (Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, Syphilis, Inflammatory Diseases, Diabetes, Others), Analysis Mode (Serum, Plasma, Blood), End-User (Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home, Others), Product Type (Kits, Reagents)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Thermo Fisher Scientific, Inc. (U.S), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher (U.S.), Quest Diagnostics Incorporated (U.S), Siemens Healthcare GmbH (Germany), Abbott (U.S), Merck KGaA (Germany), Zoetis (U.S), Ortho Clinical Diagnostics (U.S.), Getein Biotech, Inc. (China), HORIBA, Ltd (Japan), Randox Laboratories Ltd. (U.K), Boditech Med, Inc. (South Korea)Aidian (Finland), SD Biosensor, INC. (South Korea), Teco Diagnostics (U.S), Arlington Scientific, Inc. (U.S)
|
|
Market Opportunities
|
|
C-Reactive Protein Market Dynamics
Drivers
- An exponential increase in research on various applications of the C-reactive protein
The increased use of techniques such as point-of-care (POC) based testing for reliable findings and approvals of C-reactive protein testing to diagnose bacterial and non-bacterial infections is projected to boost the market growth. Furthermore, cardiovascular disorders are rising, as is the number of tests required.
- Increasing incidence of inflammatory disorders
Inflammatory disorders such as inflammatory bowel disease, endometriosis, cancer, rheumatoid arthritis, cardiovascular disease, and lupus are all diagnosed with C-reactive protein tests. When high CRP is combined with other risk factors such as hypertension, high blood pressure, diabetes, and high cholesterol, it can suggest significant heart disease. Early identification of these disorders can significantly lower the risk of heart attacks and strokes. CRP is used to discover novel medicines for inflammatory illnesses in vitro and in vivo.
- Growing cases of endometriosis in women
Endometriosis is when the uterine tissue grows outside of the uterus. The disease most commonly affects a woman's ovaries, fallopian tubes, and pelvic tissue. The condition has the potential to expand beyond the pelvic area. Endometriosis patients have a higher sensitivity to C-reactive protein than non-endometriosis patients. As a result, the test is widely used to detect the disease in patients.
Opportunities
A high C-reactive protein level in a patient with a previous heart attack history has a significant risk of having another heart attack. Hence, the C-reactive protein test can help determine the risk of a second heart attack. Furthermore, according to the study, liver cells create C-reactive protein, which is employed as a marker for determining cardiovascular disease. Patients suffering from autoimmune disorders such as rheumatoid arthritis and lupus are frequently tested for C-reactive protein, as these diseases produce inflammation.
Restraints/Challenges
The scarcity of competent and trained professionals and the availability of alternatives in the market are both factors limiting market growth.
This C-reactive protein market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the C-reactive protein market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on C-Reactive Protein Market
The continuing COVID-19 epidemic is likely to boost the market's performance. CRP has been evaluated as a prognostic predictor in COVID-19 number of studies. For example, in November 2020, researchers patients in a from the United States published a paper. The study found that daily CRP readings are helpful in COVID-19 patients who are hospitalized. CRP levels can potentially be used as early warning indicators. The need for CRP testing in the region is expected to rise due to these investigations.
Recent Development
- In October 2018, RPS Diagnostics, Inc reported that its FebriDx test had gained the CE mark. Within 10 minutes, doctors will be able to examine the body's immune response to an acute respiratory infection using a fingerstick blood sample. This device was created specifically to detect various conditions and ARI.
Global C-Reactive Protein Market Scope
The C-reactive protein market is segmented on the basis of assay type, detection range, disease, analysis mode, product type and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Assay Type
- Immunoturbidimetric Assay
- ELISA
- Chemiluminescence Immunoassay
- Others
Detection Range
- hs-CRP
- Conventional CRP
- cCRP
Disease
- Cardiovascular Diseases
- Cancer
- Rheumatoid Arthritis
- Inflammatory Bowel Disease
- Endometriosis
- Lupus
- Syphilis
- Inflammatory Diseases
- Diabetes
- Others
Analysis Mode
- Serum
- Plasma
- Blood
End- User
- Clinics
- Hospitals
- Laboratories
- Assisted Living Healthcare Facilities
- Home
- Others
Product Type
- Kits
- Reagents
C-Reactive Protein Market Regional Analysis/Insights
The C-reactive protein market is analyzed and market size insights and trends are provided by country, assay type, detection range, disease, analysis mode, product type and end-user, as referenced above.
The countries covered in the C-reactive protein market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America is anticipated to dominate the market in the forecast period due to favorable reimbursement policies.
Asia Pacific is anticipated to be the fastest-growing market region due to increasing government initiative toward R&D projects and improving the healthcare sector. Besides, progression in technology will boost the market growth in the coming years.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The C-reactive protein market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for C-reactive protein market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the C-reactive protein market. The data is available for historic period 2010-2020.
Competitive Landscape and C-Reactive Protein Market Share Analysis
The C-reactive protein market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies focus related to C-reactive protein market.
Some of the major players operating in the C-reactive protein market are:
- Thermo Fisher Scientific, Inc. (U.S)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Danaher (U.S.)
- Quest Diagnostics Incorporated (U.S)
- Siemens Healthcare GmbH (Germany)
- Abbott (U.S)
- Merck KGaA (Germany)
- Zoetis (U.S)
- Ortho Clinical Diagnostics (U.S.)
- Getein Biotech, Inc. (China)
- HORIBA, Ltd (Japan)
- Randox Laboratories Ltd. (U.K)
- Boditech Med, Inc. (South Korea)
- Aidian (Finland)
- SD Biosensor, INC. (South Korea)
- Teco Diagnostics (U.S)
- Arlington Scientific, Inc. (U.S)
SKU-